Skip to main content
Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
152.43
-2.15 (-1.39%)
Feb 21, 2025, 4:00 PM EST - Market closed

Ascendis Pharma Revenue

In the year 2024, Ascendis Pharma had annual revenue of 363.64M EUR with 36.34% growth. Ascendis Pharma had revenue of 173.92M in the quarter ending December 31, 2024, with 26.30% growth.

Revenue (ttm)
363.64M EUR
Revenue Growth
+36.34%
P/S Ratio
23.44
Revenue / Employee
357,562 EUR
Employees
1,017
Market Cap
9.12B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024363.64M96.92M36.34%
Dec 31, 2023266.72M215.54M421.20%
Jan 1, 202351.17M43.40M557.93%
Dec 31, 20217.78M825.00K11.87%
Dec 31, 20206.95M-6.42M-48.01%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

ASND News

More News